Stock Movers: Novo Nordisk Pill Approval, Huntington Ingalls New Warships, Orsted Wind Farm Leases Suspended

Novo Nordisk Secures Pill Approval for Wegovy

• 💊 Novo Nordisk received US approval for a pill version of its Wegovy obesity drug, aiming to launch in early January at approximately $140-$149 per dose.
• 📉 Despite the approval, the stock has nearly halved in value this year, facing competition from Eli Lilly in the obesity market.
• 🚀 The pill is expected to broaden the market by appealing to individuals who prefer not to use injections and offers a potentially lower-priced option.

Huntington Ingalls Industries to Build New Warships

• 🚢 Huntington Ingalls Industries (HII) saw its stock climb following President Trump's announcement of a new "Trump-class" of warships.
• ⚓ The company is set to build a new frigate for the U.S. Navy, with the CEO expressing confidence in their shipbuilding capabilities.
• 💥 Trump described the new ships as potentially 30,000-40,000 tons, equipped with nuclear cruise missiles, hypersonic weapons, and electric rail guns, and made with steel.
• 📈 The company's stock has already surged 88% this year.

Orsted Faces Suspension of Wind Farm Leases

• 💨 Orsted's shares declined after the U.S. suspended leases for five offshore wind farms under construction off the East Coast.
• ⚠️ The U.S. Interior Department cited national security concerns, suggesting the turbines might interfere with radar systems.
• ⚖️ Orsted is considering all options, including legal action, in response to the U.S. decision regarding the Revolution Wind and Sunrise Wind projects.